Docplexus News brings you the latest happenings in the field of medical science.
Top Stories of the Day:
Mechanism of Action of Siponimod
Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified how Siponimod, a drug for multiple sclerosis, can act as a targeted drug, interacting with its target receptor S1P1, an additional receptor S1P5, but not with any other unwanted receptors.
This Week's Trending News JUST for You. Listen to 'Docplexus Health Minute' from Monday to Friday and 'Health Minute Highlights' on Saturday & Sunday!
No comments:
Post a Comment